Microbix Biosystems Inc. reported earnings results for the full year ended September 30, 2023. For the full year, the company reported revenue was CAD 16.51 million compared to CAD 19.08 million a year ago. Net loss was CAD 0.039483 million compared to net income of CAD 1.79 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.325 CAD | -2.99% | -4.41% | -16.67% |
Apr. 25 | Microbix to Present New Lab Accreditation Program at European Congress on Clinical Microbiology | MT |
Mar. 27 | Transcript : Microbix Biosystems Inc. - Shareholder/Analyst Call |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.67% | 32.62M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- MBX Stock
- News Microbix Biosystems Inc.
- Microbix Biosystems Inc. Reports Earnings Results for the Full Year Ended September 30, 2023